In the study, 33 percent of patients receiving upadacitinib achieved clinical remission (per Adapted
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.6 USD | -4.58% | -4.08% | +3.00% |
04-26 | Health Care Flat After Strong Earnings Week -- Health Care Roundup | DJ |
04-26 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
In the study, 33 percent of patients receiving upadacitinib achieved clinical remission (per Adapted
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+3.00% | 283B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |